About: Bio-Israel

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam libero diam, elementum eget porttitor at, tincidunt at nulla.

Recent Posts by Bio-Israel

Can-Fite: Ophthalix Drug Effective for Eye Disease

OphthaliX (OTCBB: OPLI) has completed preclinical studies showing that its CF101 drug candidate is efficacious in treating Anterior Uveitis. The pre-clinical study data demonstrated that CF101 is efficacious in preventing the clinical manifestations of Anterior Uveitis in a well-established animal model. The current study data together with the previous published...
Read more

Foamix Topical Foam Patented

Foamix has obtained a US Patent for its “Waterless Hydrophilic Foam” for Dermatological and Gynecological Drugs, such as Antibiotics, Antifungals, Corticosteroids, and Drugs for Psoriasis and Atopic Dermatitis. US Patent No. 8,114,385 , entitled “Oleaginous pharmaceutical and cosmetic foam ” covers a platform of versatile polyethylene glycol-based foam formulations, which...
Read more

BioPharma Equipment Pages Launched

GoIndustry DoveBid (LSE: GOI) has launched new industry-focused pages on its website, www.go-dove.com, in order to highlight its service offerings to a wide range of industries. The new pages can be accessed immediately at www.go-dove.com/industry and span the industries of BioPharma, Broadcast, Computing, Electronics, Food Services, Industrial, Transportation and more....
Read more

Canine VacciCheck Reaches U.S. Market

The Spectrum Group will market Biogal-Galed Labs’ VacciCheck™ product in the US pet market. The Canine VacciCheck™ kit is intended to be used as an in-house diagnostic tool to evaluate the amount of antibodies present for the core vaccines (Canine Infectious Hepatitis-Adenovirus Type 2, Canine Parvovirus, and Canine Distemper Virus)....
Read more

Redhill Trial for Migraine

RedHill Biopharma Ltd. (TASE: RDHL), has announced the commencement of a pivotal bioequivalence clinical trial with RHB-103, an oral thin-film formulation of a leading triptan for the treatment of acute migraine. RedHill has completed screening and recruitment of all subjects for this clinical trial and announced subjects’ first dosing on...
Read more

Recent Comments by Bio-Israel

    No comments by Bio-Israel yet.